Each quarter, funds are required to disclose their portfolios to the Securities & Exchange Commission (SEC) via 13F filing.

These filings disclose long U.S. equity positions, American Depositary Receipts (ADRs), stock options (puts/calls), warrants, as well as convertible notes. They do not disclose positions in other asset classes (such as commodities, currencies, or debt). They also do not reveal foreign market holdings, short sales or cash positions.

In this article, we will summarize the 2016 Q3 13F filings of 36 top funds.  

Fund Consensus Buy List

Apple Inc...

Read more

by InsiderRank | Nov 23, 2016 | 0 Comments


Autobytel (NASDAQ:ABTL) CEO, CFO and four different officers purchased 13,084 shares of the stock on the open market in transactions dated between November 17th to November 25th. The stock was purchased at an average price of $10.71 per share, with a total value of $140,083.

Shares of Autobytel traded up 0.84% on Wednesday, hitting $10.77. 105,253 shares of the company’s stock traded han...

Read more

by InsiderRank | Nov 29, 2014 | 0 Comments


Accuray (NASDAQ:ARAY) CEO Levine Joshua purchased 100,000 shares of the stock on the open market in a transaction dated November 3th. The purchase is weighted 12.3% of his whole holdings. The stock was purchased at price of $6.34 per share, with a total value of $634,000. Following the completion of the purchase, the CEO now directly owns 811,634 shares of the company’s stock, valued at approximately $5,437,947.

Read more

by InsiderRank | Nov 5, 2014 | 0 Comments


Gigamon (NASDAQ:GIMO)’s director Michael C. Ruettgers bought 20,000 shares of the stock on the open market on October 30th for $280,400, an average of $14.02 each. Following the completion of the purchase, the director now directly owns 20,000 shares of Gigamon LLC.


big

Shares of Gi...

Read more

by InsiderRank | Nov 1, 2014 | 0 Comments


Pluristem Therapeutics Inc. is a leading developer of placenta-based cell therapies. The Company's patented PLX (PLacental eXpanded) cells are a drug delivery platform that releases a cocktail of therapeutic proteins in response to local and systemic inflammatory and ischemic diseases. These diseases collectively cost the U.S. healthcare system tens of billions of dollars. PLX cells are grown using the Company's proprietary 3D expansion technology and are an "off-the-shelf" product that requires no tissue matching prior to administration. Pluristem has a strong intellectual property position, Company-ow...

Read more

by InsiderRank | Oct 7, 2014 | 0 Comments


According to a Form4 filed on September 17, Bill Gates’s Cascade Investment, LLC bought 1,290,200 shares of Republic Service Inc (RSG) for $50,653,200, an average of $39.26 each. They now directly owns 104,150,012 shares of Republic Service Inc, a stake of 30%.



Cascade Invest...

Read more

by InsiderRank | Sep 21, 2014 | 0 Comments